Evidence map›Paper›PMID 22858695›Full record

ReviewJournal of applied oral science : revista FOB

Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Geisla Mary Silva Soares, Luciene Cristina Figueiredo, Marcelo Faveri, Sheila Cavalca Cortelli, Poliana Mendes Duarte, Magda Feres

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of applied oral science : revista FOB. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Efficacy of Laser Therapy for Grade C Periodontitis in Young Individuals.International journal of medical sciences · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Emergence of Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Life (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Geisla Mary Silva SoaresDepartment of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, SP, Brazil.
Luciene Cristina Figueiredo
Marcelo Faveri
Sheila Cavalca Cortelli
Poliana Mendes Duarte
Magda Feres
Guarulhos University · BRUniversidade de Taubaté · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics are important adjuncts in the treatment of infectious diseases, including periodontitis. The most severe criticisms to the indiscriminate use of these drugs are their side effects and, especially, the development of bacterial resistance. The knowledge of the biological mechanisms involved with the antibiotic usage would help the medical and dental communities to overcome these two problems. Therefore, the aim of this manuscript was to review the mechanisms of action of the antibiotics most commonly used in the periodontal treatment (i.e. penicillin, tetracycline, macrolide and metronidazole) and the main mechanisms of bacterial resistance to these drugs. Antimicrobial resistance can be classified into three groups: intrinsic, mutational and acquired. Penicillin, tetracycline and erythromycin are broad-spectrum drugs, effective against gram-positive and gram-negative microorganisms. Bacterial resistance to penicillin may occur due to diminished permeability of the bacterial cell to the antibiotic; alteration of the penicillin-binding proteins, or production of β-lactamases. However, a very small proportion of the subgingival microbiota is resistant to penicillins. Bacteria become resistant to tetracyclines or macrolides by limiting their access to the cell, by altering the ribosome in order to prevent effective binding of the drug, or by producing tetracycline/macrolide-inactivating enzymes. Periodontal pathogens may become resistant to these drugs. Finally, metronidazole can be considered a prodrug in the sense that it requires metabolic activation by strict anaerobe microorganisms. Acquired resistance to this drug has rarely been reported. Due to these low rates of resistance and to its high activity against the gram-negative anaerobic bacterial species, metronidazole is a promising drug for treating periodontal infections.

Indexed as

Anti-Bacterial AgentsBacteriaCell Membrane PermeabilityDrug Resistance, BacterialHumansMacrolidesMetronidazolePenicillin ResistancePeriodontal DiseasesTetracycline ResistanceAnti-Bacterial AgentsMacrolidesMetronidazole

Identifiers

PMID22858695
PMCPMC3881775
OpenAlexW2124823728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.